Professor Hisham Mehanna

InHANSE, Institute of Cancer and Genomic Sciences, University of Birmingham

Professor Mehanna is the Chair of Head and Neck Surgery, and Director of InHANSE, at the University of Birmingham.

Hisham’s clinical interests are recurrence head and neck cancer surgery and thyroid and minimal access parathyroid surgery.

Hisham has a keen interest in clinical and translational research, heading a research team of 20 researchers, and holding over £10million in research grants. The main areas of his research are Human Papillomavirus-associated head and neck cancer and thyroid cancer. His research themes are drug development and redeployment, biomarkers of treatment response and early and late phase clinical trials in head and neck cancer. He is chief investigator of several multicentre and multinational clinical trials, including the PET NECK trial, published in the NEJM in 2016.

He is currently President of the British Association of Head Neck Oncologists (BAHNO) and past Chair of the Research Committee of BAHNO, the UK’s multi-disciplinary professional body, and past Chair of the UK’s National Cancer Research Institute’s head and neck group, responsible for all head neck cancer research in the UK.

dont miss

Clinical trials that change patient care and the lessons learnt

We will give examples of studies in head and neck cancer that have changed patient care, and the lessons learnt in running these studies.

Professor Hisham Mehanna will be speaking in the following theatre:

Theatre 11 - Wednesday 14.45 - 15.15: Clinical trials that change patient care and the lessons learnt

EVEN MORE SEMINARS

  • Joanne Edwards: Speaking at the Oncology Convention

    Joanne Edwards
    University of Glasgow

    Role of IKK alpha in Breast Cancer

  • Dr. Anna ME Bruynzeel: Speaking at the Oncology Convention

    Dr. Anna ME Bruynzeel
    Amsterdam UMC (formerly VUmc)

    MR Guided Adaptive Radiation Therapy; three years of clinical experience at VUmc

  • James Flanagan: Speaking at the Oncology Convention

    James Flanagan
    Imperial College London

    Epigenetic biomarkers for platinum response in ovarian cancer

  • Bertil RR Persson: Speaking at the Oncology Convention

    Bertil RR Persson
    Scandinavian ChemoTech AB. Sweden

    Dynamic-ElectroEnhanced Chemotherapy brings relief to patients with large tumour burden

  • Simon Walker-Samuel: Speaking at the Oncology Convention

    Simon Walker-Samuel
    University College London

    Using medical imaging with machine learning to develop efficient tools for diagnosing cancer